Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia

Khan Behlol Ayaz Ahmed, Santanu Kar Mahapatra, Mamilla R. Charan Raja, Shankar Subramaniam, Sengan Megarajan, N. Rajendran, Sandeep Kumar Das, Kuntal Haldar, Somenath Roy, Aravind Sivasubramanian,

RSC Advances · 2016 · 25 citations · 39 references

Concepts

Abstract

Silver nanoparticles enhance the anticancer efficacy of shikonin derivatives.

References

39